BioTime Commences Rights Offering.BERKELEY, Calif.--(BUSINESS WIRE)--Jan. 13, 1997--BioTime Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :BTIM) announced that it commenced its rights offering under which it will offer 283,109 common shares to its shareholders. Shareholders will receive one right for each share owned. The rights entitle en·ti·tle tr.v. en·ti·tled, en·ti·tling, en·ti·tles 1. To give a name or title to. 2. To furnish with a right or claim to something: the holders to purchase one common share for each ten rights owned at a subscription price of $20 per share. Shareholders who exercise all of their rights in full will be entitled en·ti·tle tr.v. en·ti·tled, en·ti·tling, en·ti·tles 1. To give a name or title to. 2. To furnish with a right or claim to something: to the additional privilege of subscribing for and purchasing, subject to certain limitations and subject to allocation, any common shares not acquired by other holders of rights through the exercise of the rights. The rights offering will expire at 5 p.m. New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of time on Feb. 4, 1997. The record date for determining BioTime shareholders entitled to receive the rights is Dec. 27, 1996. The rights are transferable and have been approved for trading on the NASDAQ SmallCap market, commencing Jan. 14, 1997. American Stock Transfer & Trust Co. will act as the Subscription Agent for the Rights offering. BioTime, headquartered in Berkeley, is engaged in the research and development of synthetic blood plasma blood plasma n. The yellow or gray-yellow, protein-containing fluid portion of blood in which the blood cells and platelets are normally suspended. volume expanders and low temperature blood substitute solutions and technology for use in surgery, emergency trauma treatment, the preservation of organs awaiting transplant transplant or graft Partial or complete organ or other body part removed from one site and attached at another. It may come from the same or a different person or an animal. One from the same person—most often a skin graft—is not rejected. , and other applications. CONTACT: BioTime Inc., Berkeley Victoria Bellport, 510/845-9535 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion